Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway

Experimental and Clinical Cardiology

Volumn 16, Issue 4, 2011, Pages 109-115

  Shaheen, Mazen ^a   Cheema, Yaser ^a   Shahbaz, Atta U ^a   Bhattacharya, Syamal K ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antioxidant defenses; Calcium overloading; Cardiomyocyte necrosis; Catecholamines; Mitochondria; Oxidative stress; Parathyroid hormone

Indexed keywords

CALCIUM ION; CARVEDILOL; CATECHOLAMINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOSPORIN A; DOXORUBICIN; NEBIVOLOL; PARATHYROID HORMONE; POTASSIUM ION; QUERCETIN; REACTIVE OXYGEN METABOLITE; SELENIUM; ZINC ION;

ACUTE STRESS; ANTIOXIDANT ACTIVITY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CHRONIC STRESS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EXTRACELLULAR CALCIUM; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; HYPOCALCEMIA; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SECONDARY HYPERPARATHYROIDISM; SIGNAL TRANSDUCTION;

EID: 80055118501     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Singal PK, Matsukubo MP, Dhalla NS. Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol 1979;60:96-106. (Pubitemid 9216949)
2. Singh RP, Schellenberg D, Weinberg L, Singal PK. Effects of ouabain on calcium paradox in rat hearts. Can J Physiol Pharmacol 1986;64:235-9. (Pubitemid 16113366)
3. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982;60:1390-7. (Pubitemid 13209544)
4. Singal PK, Beamish RE, Dhalla NS. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1983;161:391-401.
5. Kirshenbaum LA, Thomas TP, Randhawa AK, Singal PK. Time-course of cardiac myocyte injury due to oxidative stress. Mol Cell Biochem 1992;111:25-31.
6. Kirshenbaum LA, Singal PK. Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol 1993;265:H484-H93.
7. Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994;89:2829-35. (Pubitemid 24173705)
8. Khaper N, Rigatto C, Seneviratne C, Li T, Singal PK. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol 1997;29:3335-44. (Pubitemid 28039367)
9. Li T, Singal PK. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 2000;102:2105-10.
10. Li T, Danelisen I, Bello-Klein A, Singal PK. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res 2000;46:523-30. (Pubitemid 30319337)
11. Khullar M, Al-Shudiefat AA, Ludke A, Binepal G, Singal PK. Oxidative stress: A key contributor to diabetic cardiomyopathy. Can J Physiol Pharmacol 2010;88:233-40.
12. Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-63. (Pubitemid 24026485)
13. Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002;89:691-5. (Pubitemid 34230565)
14. Kuwabara Y, Sato Y, Miyamoto T, et al. Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J 2007;71:1047-51. (Pubitemid 46998018)
15. Peacock WF IV, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-26. (Pubitemid 351679598)
16. Zairis MN, Tsiaousis GZ, Georgilas AT, et al. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 2009;141:284-90.
17. Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest 2004;64:667-76. (Pubitemid 39425306)
18. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-8. (Pubitemid 37022125)
19. Sukova J, Ostadal P, Widimsky P. Profile of patients with acute heart failure and elevated troponin I levels. Exp Clin Cardiol 2007;12:153-6. (Pubitemid 47520918)
20. Ilva T, Lassus J, Siirilä-Waris K, et al. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008;10:772-9.
21. Sato Y, Nishi K, Taniguchi R, et al. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. J Cardiol 2009;54:221-30.
22. Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2009;54:1715-21.
23. Fleckenstein A, Kanke J, Döring HJ, Leder O. Key role of Ca in the production of noncoronarogenic myocardial necroses. Recent Adv Stud Cardiac Struct Metab 1975;6:21-32.
24. Lossnitzer K, Janke J, Hein B, Stauch M, Fleckenstein A. Disturbed myocardial calcium metabolism: A possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster. Recent Adv Stud Cardiac Struct Metab 1975;6:207-17.
25. Tan LB, Burniston JG, Clark WA, Ng Y, Goldspink DF. Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agents: Toward a new bioassay for beta-blockers. J Cardiovasc Pharmacol 2003;41:518-25. (Pubitemid 36373788)
26. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: The same or separate death pathways? Exp Physiol 2004;89:407-16. (Pubitemid 39023182)
27. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989;65:657-70. (Pubitemid 19226442)
28. Bier CB, Rona G. Mineralocorticoid potentiation of isoproterenol-induced myocardial injury: Ultrastructural equivalent. J Mol Cell Cardiol 1979;11:961-6. (Pubitemid 10165479)
29. Rona G, Boutet M, Huttner I. Reperfusion injury. A possible link between catecholamine-induced and ischemic myocardial alterations. Adv Myocardiol 1983;4:427-39.
30. Yates JC, Taam GM, Singal PK, Beamish RE, Dhalla NS. Modification of adrenochrome-induced cardiac contractile failure and cell damage by changes in cation concentrations. Lab Invest 1980;43:316-26. (Pubitemid 10008957)
31. Singal PK, Forbes MS, Sperelakis N. Occurrence of intramitochondrial Ca2+ granules in a hypertrophied heart exposed to adriamycin. Can J Physiol Pharmacol 1984;62:1239-44. (Pubitemid 14023275)
32. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008;118:397-409.
33. Shahbaz AU, Zhao T, Zhao W, et al. Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state. Am J Physiol Heart Circ Physiol 2011;300:H636-H44.
34. Rushmer RF, Thal N. The mechanics of ventricular contraction; a cinefluorographic study. Circulation 1951;4:219-28.
35. Sedmera D, Reckova M, Bigelow MR, et al. Developmental transitions in electrical activation patterns in chick embryonic heart. Anat Rec A Discov Mol Cell Evol Biol 2004;280:1001-9. (Pubitemid 39319324)
36. Buchalter MB, Rademakers FE, Weiss JL, Rogers WJ, Weisfeldt ML, Shapiro EP. Rotational deformation of the canine left ventricle measured by magnetic resonance tagging: Effects of catecholamines, ischaemia, and pacing. Cardiovasc Res 1994;28:629-35. (Pubitemid 24199176)
37. Whitted AD, Stanifer JW, Dube P, et al. A dyshomeostasis of electrolytes and trace elements in acute stressor states: Impact on the heart. Am J Med Sci 2010;340:48-53.
38. Carlstedt F, Lind L, Joachimsson PO, Rastad J, Wide L, Ljunghall S. Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery. Scand J Clin Lab Invest 1999;59:47-53.
39. Carlstedt F, Lind L, Rastad J, Stjernstrom H, Wide L, Ljunghall S. Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients. Eur J Clin Invest 1998;28:898-903. (Pubitemid 28521580)
40. Carlstedt F, Lind L, Wide L, et al. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 1997;27:977-81. (Pubitemid 28012617)
41. Hästbacka J, Pettilä V. Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand 2003;47:1264-9. (Pubitemid 37452603)
42. Choi YC, Hwang SY. The value of initial ionized calcium as a predictor of mortality and triage tool in adult trauma patients. J Korean Med Sci 2008;23:700-5.
43. Cherry RA, Bradburn E, Carney DE, Shaffer ML, Gabbay RA, Cooney RN. Do early ionized calcium levels really matter in trauma patients? J Trauma 2006;61:774-9. (Pubitemid 44569402)
44. Dickerson RN, Henry NY, Miller PL, Minard G, Brown RO. Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support. Nutr Clin Pract 2007;22:323-8.
45. Burchard KW, Simms HH, Robinson A, DiAmico R, Gann DS. Hypocalcemia during sepsis. Relationship to resuscitation and hemodynamics. Arch Surg 1992;127:265-72.
46. Joborn H, Hjemdahl P, Larsson PT, et al. Platelet and plasma catecholamines in relation to plasma minerals and parathyroid hormone following acute myocardial infarction. Chest 1990;97:1098-105. (Pubitemid 20166797)
47. Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: Relationship to infarct extent and mortality. Am Heart J 1981;102:24-9. (Pubitemid 11086984)
48. Magnotti LJ, Bradburn EH, Webb DL, et al. Admission ionized calcium levels predict the need for multiple transfusions: A prospective study of 591 critically ill trauma patients. J Trauma 2011;70:391-7.
49. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197-207. (Pubitemid 27413402)
50. Khouzam RN, Dishmon DA, Farah V, Flax SD, Carbone LD, Weber KT. Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 2006;331:30-4. (Pubitemid 43177513)
51. LaGuardia SP, Dockery BK, Bhattacharya SK, Nelson MD, Carbone LD, Weber KT. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci 2006;332:112-8. (Pubitemid 44401230)
52. Arroyo M, LaGuardia SP, Bhattacharya SK, et al. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res 2006;148:301-8. (Pubitemid 44880038)
53. Alsafwah S, LaGuardia SP, Nelson MD, et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008;335:292-7. (Pubitemid 351548648)
54. Fertig A, Webley M, Lynn JA. Primary hyperparathyroidism in a patient with Conn's syndrome. Postgrad Med J 1980;56:45-7. (Pubitemid 10214686)
55. Hellman DE, Kartchner M, Komar N, Mayes D, Pitt M. Hyperaldosteronism, hyperparathyroidism, medullary sponge kidneys, and hypertension. JAMA 1980;244:1351-3. (Pubitemid 10003883)
56. Resnick LM, Laragh JH. Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 1985;78:385-90. (Pubitemid 15107917)
57. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 1995;8:884-93.
58. Brunaud L, Germain A, Zarnegar R, et al. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery 2009;146:1035-41.
59. Chhokar VS, Sun Y, Bhattacharya SK, et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005;111:871-8. (Pubitemid 40279888)
60. Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT. Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006;290:H286-H94.
61. Selektor Y, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism. Am J Med Sci 2008;335:105-10. (Pubitemid 351253405)
62. Gandhi MS, Deshmukh PA, Kamalov G, et al. Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism. J Cardiovasc Pharmacol 2008;52:245-52.
63. Kamalov G, Deshmukh PA, Baburyan NY, et al. Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism. J Cardiovasc Pharmacol 2009;53:414-23.
64. Lee AH, Mull RL, Keenan GF, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35-41. (Pubitemid 24043650)
65. Schmid C, Kiowski W. Hyperparathyroidism in congestive heart failure. Am J Med 1998;104:508-9.
66. Ogino K, Ogura K, Kinugasa Y, et al. Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure. J Clin Endocrinol Metab 2002;87:4722-7. (Pubitemid 35247067)
67. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105-12. (Pubitemid 36044411)
68. Sugimoto T, Tanigawa T, Onishi K, et al. Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart 2009;95:395-8.
69. Pilz S, Tomaschitz A, Drechsler C, et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010;31:1591-8.
70. Hagström E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009;119:2765-71.
71. Hagström E, Ingelsson E, Sundström J, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 2010;12:1186-92.
72. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985;76:470-3. (Pubitemid 15227507)
73. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, Butros R, Wedlund PJ, Fanti P. Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol 2002;57:51-5. (Pubitemid 34071626)
74. Zittermann A, Fischer J, Schleithoff SS, Tenderich G, Fuchs U, Koerfer R. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res 2007;77:280-8. (Pubitemid 350114349)
75. Zittermann A, Schleithoff SS, Gotting C, et al. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008;10:321-7.
76. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007;18:41-6. (Pubitemid 46090236)
77. Borkowski BJ, Cheema Y, Shahbaz AU, Bhattacharya SK, Weber KT. Cation dyshomeostasis and cardiomyocyte necrosis. The Fleckenstein hypothesis revisited. Eur Heart J 2011. (In press)
78. Cohen AJ, Roe FJ. Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem Toxicol 2000;38:237-53. (Pubitemid 30136274)
79. Teucher B, Dainty JR, Spinks CA, et al. Sodium and bone health: Impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J Bone Miner Res 2008;23:1477-85.
80. Kerschan-Schindl K, Strametz-Juranek J, Heinze G, et al. Pathogenesis of bone loss in heart transplant candidates and recipients. J Heart Lung Transplant 2003;22:843-50. (Pubitemid 36945480)
81. Nishio K, Mukae S, Aoki S, et al. Congestive heart failure is associated with the rate of bone loss. J Intern Med 2003;253:439-46. (Pubitemid 36418929)
82. Kenny AM, Boxer R, Walsh S, Hager WD, Raisz LG. Femoral bone mineral density in patients with heart failure. Osteoporos Int 2006;17:1420-7. (Pubitemid 44127330)
83. Frost RJ, Sonne C, Wehr U, Stempfle HU. Effects of calcium supplementation on bone loss and fractures in congestive heart failure. Eur J Endocrinol 2007;156:309-14. (Pubitemid 46554498)
84. Abou-Raya S, Abou-Raya A. Osteoporosis and congestive heart failure (CHF) in the elderly patient: Double disease burden. Arch Gerontol Geriatr 2009;49:250-4.
85. van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA. Heart failure is a risk factor for orthopedic fracture: A population-based analysis of 16,294 patients. Circulation 2008;118:1946-52.
86. Carbone LD, Cross JD, Raza SH, et al. Fracture risk in men with congestive heart failure. Risk reduction with spironolactone. J Am Coll Cardiol 2008;52:135-8. (Pubitemid 351885442)
87. Law PH, Sun Y, Bhattacharya SK, Chhokar VS, Weber KT. Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol 2005;46:142-6. (Pubitemid 40905142)
88. Singal PK, Kirshenbaum LA. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 1990;6:47-9.
89. Dhaliwal H, Kirshenbaum LA, Randhawa AK, Singal PK. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol 1991;261:H632-H8.
90. Kirshenbaum LA, Singal PK. Antioxidant changes in heart hypertrophy: Significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 1992;70:1330-5. (Pubitemid 23045707)
91. Garcia Zozaya JL, Padilla Viloria M. [Alterations of calcium, magnesium, and zinc in essential hypertension: Their relation to the renin-angiotensin- aldosterone system.] Invest Clin 1997;38(Suppl 2):27-40.
92. Tubek S. Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension. Biol Trace Elem Res 2005;107:89-99. (Pubitemid 41417099)
93. Golik A, Modai D, Averbukh Z, et al. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990;39:665-7. (Pubitemid 20198256)
94. Golik A, Zaidenstein R, Dishi V, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 1998;17:75-8. (Pubitemid 28081145)
95. Chmielnicka J, Zareba G, Witasik M, Brzeznicka E. Zinc-selenium interaction in the rat. Biol Trace Elem Res 1988;15:267-76.
96. Kamalov G, Ahokas RA, Zhao W, et al. Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol 2010;298:H385-H94.
97. Kamalov G, Ahokas RA, Zhao W, et al. Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism. J Cardiovasc Pharmacol 2010;55:248-54.
98. Wang J, Song Y, Elsherif L, et al. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 2006;113:544-54.
99. Chung MJ, Hogstrand C, Lee SJ. Cytotoxicity of nitric oxide is alleviated by zinc-mediated expression of antioxidant genes. Exp Biol Med (Maywood) 2006;231:1555-63. (Pubitemid 44547850)
100. Chung MJ, Walker PA, Brown RW, Hogstrand C. Zinc-mediated gene expression offers protection against H2O2-induced cytotoxicity. Toxicol Appl Pharmacol 2005;205:225-36. (Pubitemid 40726298)
101. Singal PK, Dhillon KS, Beamish RE, Dhalla NS. Protective effect of zinc against catecholamine-induced myocardial changes electrocardiographic and ultrastructural studies. Lab Invest 1981;44:426-33. (Pubitemid 11105374)
102. Chvapil M, Owen JA. Effect of zinc on acute and chronic isoproterenol induced heart injury. J Mol Cell Cardiol 1977;9:151-9. (Pubitemid 8024772)
103. Prabhu KS, Zamamiri-Davis F, Stewart JB, Thompson JT, Sordillo LM, Reddy CC. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: Role of nuclear factor-kB in up-regulation. Biochem J 2002;366 (Pt 1):203-9. (Pubitemid 34971819)
104. Hatanaka N, Nakaden H, Yamamoto Y, Matsuo S, Fujikawa T, Matsusue S. Selenium kinetics and changes in glutathione peroxidase activities in patients receiving long-term parenteral nutrition and effects of supplementation with selenite. Nutrition 2000;16:22-6. (Pubitemid 30050720)
105. Weiss SL, Evenson JK, Thompson KM, Sunde RA. The selenium requirement for glutathione peroxidase mRNA level is half of the selenium requirement for glutathione peroxidase activity in female rats. J Nutr 1996;126:2260-7. (Pubitemid 26313604)
106. Xia YM, Hill KE, Burk RF. Biochemical studies of a selenium-deficient population in China: Measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood. J Nutr 1989;119:1318-26. (Pubitemid 19268010)
107. van Rij AM, Thomson CD, McKenzie JM, Robinson MF. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr 1979;32:2076-85. (Pubitemid 10244805)
108. Reeves WC, Marcuard SP, Willis SE, Movahed A. Reversible cardiomyopathy due to selenium deficiency. JPEN J Parenter Enteral Nutr 1989;13:663-5. (Pubitemid 20005572)
109. Boldery R, Fielding G, Rafter T, Pascoe AL, Scalia GM. Nutritional deficiency of selenium secondary to weight loss (bariatric) surgery associated with life-threatening cardiomyopathy. Heart Lung Circ 2007;16:123-6. (Pubitemid 46436715)
110. Shahbaz AU, Kamalov G, Zhao W, et al. Mitochondria-targeted cardioprotection in aldosteronism. J Cardiovasc Pharmacol 2011;57:37-43.
111. Cheema Y, Sherrod JN, Shahbaz AU, et al. Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: Cardioprotective responses to carvedilol and nebivolol. J Cardiovasc Pharmacol 2011;58:80-6.
112. Song Y, Wang J, Li XK, Cai L. Zinc and the diabetic heart. Biometals 2005;18:325-32. (Pubitemid 41298016)
113. Demling RH, DeBiasse MA. Micronutrients in critical illness. Crit Care Clin 1995;11:651-73.
114. Sriram K, Lonchyna VA. Micronutrient supplementation in adult nutrition therapy: Practical considerations. JPEN J Parenter Enteral Nutr 2009;33:548-62.
115. Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol 2001;37:1765-74. (Pubitemid 32499957)
116. Soukoulis V, Dihu JB, Sole M, et al. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol 2009;54:1660-73.
117. Bhattacharya SK, Ahokas RA, Carbone LD, et al. Macro- and micronutrients in African-Americans with heart failure. Heart Fail Rev 2006;11:45-55. (Pubitemid 43986207)
118. Robinson AD, Ramanathan KB, McGee JE, Newman KP, Weber KT. Oxidative stress and cardiomyocyte necrosis with elevated serum troponins: Pathophysiologic mechanisms. Am J Med Sci 2011. (In press)
119. Kamalov G, Bhattacharya SK, Weber KT. Congestive heart failure: Where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol 2010;56:320-8.